Predictive factors for the effectiveness of novel androgen receptor axis‐targeted agents in patients with metastatic prostate cancer.

MLA

Koshiro, Nishimoto, et al. “Predictive Factors for the Effectiveness of Novel Androgen Receptor Axis‐targeted Agents in Patients with Metastatic Prostate Cancer.” International Journal of Urology, vol. 29, no. 12, Dec. 2022, pp. 1477–87. EBSCOhost, https://doi.org/10.1111/iju.15022.

APA

Koshiro, N., Nakajima, K., Oyama, M., Kaneko, G., Takahashi, S., Matsuyama, H., Shiina, H., Ichikawa, T., Horikoshi, H., Hashine, K., Sugiyama, Y., Miyao, T., Kamiyama, M., Harada, K., Ito, A., & Mizokami, A. (2022). Predictive factors for the effectiveness of novel androgen receptor axis‐targeted agents in patients with metastatic prostate cancer. International Journal of Urology, 29(12), 1477–1487. https://doi.org/10.1111/iju.15022

Chicago

Koshiro, Nishimoto, Kenichi Nakajima, Masafumi Oyama, Go Kaneko, Satoru Takahashi, Hideyasu Matsuyama, Hiroaki Shiina, et al. 2022. “Predictive Factors for the Effectiveness of Novel Androgen Receptor Axis‐targeted Agents in Patients with Metastatic Prostate Cancer.” International Journal of Urology 29 (12): 1477–87. doi:10.1111/iju.15022.